Evidence map›Paper›PMID 40273103›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Conserved C143 forms a branched intermediate in Hedgehog autoprocessing: A cancer drug discovery target against Hedgehog signaling.

Shannon Faris, Ke Xia, Andrew G Wagner, Zihan Xu, Nathan Smith, José-Luis Giner, Brian Callahan, Jian Xie, Chunyu Wang

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shannon FarisDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180.ORCID 0000-0003-2058-6160
Ke XiaCenter for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180.ORCID 0000-0001-9699-9901
Andrew G WagnerDepartment of Chemistry, Binghamton University, Binghamton, NY 13902.ORCID 0000-0003-4786-7747
Zihan XuDepartment of Chemistry, Binghamton University, Binghamton, NY 13902.ORCID 0000-0002-8647-4287
Nathan SmithCenter for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180.ORCID 0000-0001-8008-7799
José-Luis GinerDepartment of Chemistry, State University of New York-Environmental Science and Forestry, Syracuse, NY 13210.
Brian CallahanDepartment of Chemistry, Binghamton University, Binghamton, NY 13902.ORCID 0000-0003-4826-0162
Jian XieDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198.ORCID 0000-0003-1381-9704
Chunyu WangDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180.ORCID 0000-0001-5165-7959

Funding

Structural Mechanisms of Hedgehog Autoprocessing in Physiology and DiseaseR01CA206592 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI CALLAHAN, BRIAN PATRICK, WANG, CHUNYU · 2017 to 2021
$2.0M
The Alzheimer's Disease Clinical and Translational Research (ADCTR) Training ProgramT32AG057464 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI WANG, CHUNYU · 2017 to 2021
$1.6M
Orbitrap Eclipse Tribrid Mass Spectrometer as a Regional ResourceS10OD032168 · OD · RENSSELAER POLYTECHNIC INSTITUTE · PI ZHANG, FUMING · 2023 to 2023
$1.2M
Predoctoral Training Program for Alzheimer’s Disease at the Interface of Data Science, Engineering and BiologyT32AG078123 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI Chunyu Wang · 2023 to 2026
$974k
Sterol Probes of Hedgehog Protein ProcessingR15GM143714 · NIGMS · COLLEGE OF ENVIRONMENTAL SCI & FORESTRY · PI GINER, JOSE L · 2021 to 2021
$446k
Discovery and anti-tumor activity of the first antagonists targeting human Sonic Hedgehog autoprocessingR21CA282857 · NCI · STATE UNIVERSITY OF NY,BINGHAMTON · PI CALLAHAN, BRIAN PATRICK · 2024 to 2025
$402k
Biacore T200 Surface Plasmon Resonance SpectroscopyS10OD028523 · OD · RENSSELAER POLYTECHNIC INSTITUTE · PI LINHARDT, ROBERT J · 2020 to 2020
$344k
HHS | National Institutes of Health (NIH) AG057464HHS | National Institutes of Health (NIH) AG078123HHS | NIH | National Cancer Institute (NCI) CA206592HHS | NIH | National Cancer Institute (NCI) CA282857NCI NIH HHS R01 CA206592NCI NIH HHS R21 CA282857NIA NIH HHS T32 AG057464NIA NIH HHS T32 AG078123NIGMS NIH HHS R15 GM143714NIH HHS S10 OD028523NIH HHS S10 OD032168
6 · The paper itself

Abstract

Hedgehog (Hh) signaling plays fundamental roles in embryonic development while its abnormal activation in adults is associated with cancer. Hh targeting drugs have gained FDA approval but resistance emerged quickly, underlining the need for novel types of Hh inhibitors. Hh signaling is initiated by the Hh ligand, generated from the autoprocessing of Hh precursor. However, the catalytic role of a highly conserved Hedgehog residue C143 is still poorly understood. Here, we confirmed that C143 is required for Hh autoprocessing in mammalian cells. NMR titration showed that C143 has an extremely low pK

Indexed as

Antineoplastic AgentsHedgehog ProteinsSignal TransductionAnimalsDrug DiscoveryHEK293 CellsHumansNeoplasmsAntineoplastic AgentsHedgehog Proteinsbranched intermediateHedgehog proteininteins

Identifiers

PMID40273103
PMCPMC12054796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.